Hard to Treat Diseases completes cosmetic micro-conglomerate merger

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) - Further to the previously announced cosmetics merger (press release Feb 5, 2010) negotiations with the cosmetic company Melem Secrets, and other business matters the company is pleased to report that it has completed a cosmetic micro-conglomerate merger.

Collagenna Skin Care Products Inc (Collagenna) is a thriving micro cosmetics company. Collagenna briefly ventured into the public markets in 2009 and subsequently rescinded that merger upon learning that the parent company at that time had certain undisclosed legal issues. Collagenna will manage Melem Secrets and use Melem as a direct marketing company for all Collagenna product lines.

A source close to HTDS' said, "We see new and innovative products of Collagenna's as a great asset for our long anticipated expansion into cosmetic field. These companies may not show a stunning market value at the present, however revenues in the $500,000 range and projected to reach 3 million in the next 8 to 10 quarters is considered quite aggressive in any economy. Collagenna did pull its own weight and did quite good as a public company in 2009 HTDS management believes that they have great prospects for the future."

Collagenna was acquired on all cash basis therefore the existing share structure of HTDS will remain undisturbed and unchanged.

In other company news the company is continuing its research and assessment of the regenerative medicine and the stem cell bank projects. Additional information will be released as it becomes available. The company has been made aware of certain rumors circulating in the investment community that its insiders are selling their position or will sell their position in March 2010. This is untrue. All insider sales are strictly governed by SEC Rule 144 and to date no such act has taken place nor are there any plans for this in March of 2010 or in the foreseeable future.